(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. U0126 treatment and injections of mRNA encoding a MAP Kinase Phosphatase
(MKP3) or a dominant-negative Raf (dnRAF) block PMC
ingression and differentiation. (A-D) Control embryos. (E-H) Embryos treated
with 10 µM U0126, (I-L) embryos injected with MKP3 mRNA, (M-P)
dnRaf injections, (Q-T) dnRas injections. Note the absence
of PMCs in the embryos treated with UO126 (E,F), or injected with MKP3 RNA
(I,J) or dnRaf RNA (M,N). (A,E,I,M,Q) Mesenchyme blastula, (B,F,J,N,R) early
gastrula, (C,G,K,O,S) late gastrula and (D,H,L,P,T) pluteus stage. anv, anal
view. In control embryos, the PMCs ingress into the blastocoel (A) and form a
ring around the archenteron and two bilateral clusters during gastrulation
(B).